181 related articles for article (PubMed ID: 34515985)
1. Phase II, Double-Blind, Vehicle-Controlled Study to Determine the Cantharidin Dose Regimen, Efficacy, Safety, and Tolerability of VP-102 in Subjects with External Genital Warts.
Guenthner S; McFalda W; Tate M; Eads K; Rieger J; Glover DK; Willson C; Rumney P; Rosen T; Andres J; Olivadoti M
Am J Clin Dermatol; 2021 Nov; 22(6):867-875. PubMed ID: 34515985
[TBL] [Abstract][Full Text] [Related]
2. Safety and Efficacy of VP-102, a Proprietary, Drug-Device Combination Product Containing Cantharidin, 0.7% (w/v), in Children and Adults With Molluscum Contagiosum: Two Phase 3 Randomized Clinical Trials.
Eichenfield LF; McFalda W; Brabec B; Siegfried E; Kwong P; McBride M; Rieger J; Willson C; Davidson M; Burnett P
JAMA Dermatol; 2020 Dec; 156(12):1315-1323. PubMed ID: 32965495
[TBL] [Abstract][Full Text] [Related]
3. Pooled Results of Two Randomized Phase III Trials Evaluating VP-102, a Drug-Device Combination Product Containing Cantharidin 0.7% (w/v) for the Treatment of Molluscum Contagiosum.
Eichenfield LF; Siegfried E; Kwong P; McBride M; Rieger J; Glover D; Willson C; Davidson M; Burnett P; Olivadoti M
Am J Clin Dermatol; 2021 Mar; 22(2):257-265. PubMed ID: 33599960
[TBL] [Abstract][Full Text] [Related]
4. COVE-1: A Phase 2, Open-Label Study to Evaluate Efficacy and Safety and the Optimal Regimen of VP-102, a Proprietary Drug-Device Product Containing Topical Cantharidin (0.7% w/v) Under Occlusion for the Treatment of Common Warts.
Guenthner S; McFalda W; Kwong P; Eads K; McCafferty M; Rieger J; Glover DK; Willson C; Burnett P; Olivadoti M
Dermatol Ther (Heidelb); 2021 Oct; 11(5):1623-1634. PubMed ID: 34286459
[TBL] [Abstract][Full Text] [Related]
5. A Phase 2 Open-Label Study to Evaluate VP-102 for the Treatment of Molluscum Contagiosum.
Niazi S; Brabec B; Anschutz L; Willson C; Davidson M; Burnett P
J Drugs Dermatol; 2021 Jan; 20(1):70-75. PubMed ID: 33400412
[TBL] [Abstract][Full Text] [Related]
6. Topical Polyphenon E in the treatment of external genital and perianal warts: a randomized controlled trial.
Stockfleth E; Beti H; Orasan R; Grigorian F; Mescheder A; Tawfik H; Thielert C
Br J Dermatol; 2008 Jun; 158(6):1329-38. PubMed ID: 18363746
[TBL] [Abstract][Full Text] [Related]
7. YCANTH
Gupta AK; Mann A; Vincent K; Abramovits W
Skinmed; 2023; 21(5):360-363. PubMed ID: 37945366
[TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind, four-arm parallel-group, placebo-controlled Phase II/III study to investigate the clinical efficacy of two galenic formulations of Polyphenon E in the treatment of external genital warts.
Gross G; Meyer KG; Pres H; Thielert C; Tawfik H; Mescheder A
J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1404-12. PubMed ID: 17958849
[TBL] [Abstract][Full Text] [Related]
9. Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus.
Edwards L; Ferenczy A; Eron L; Baker D; Owens ML; Fox TL; Hougham AJ; Schmitt KA
Arch Dermatol; 1998 Jan; 134(1):25-30. PubMed ID: 9449906
[TBL] [Abstract][Full Text] [Related]
10. A Phase 2 Controlled Study of SB206, a Topical Nitric Oxide-Releasing Drug for Extragenital Wart Treatment.
Tyring SK; Rosen T; Berman B; Stasko N; Durham T; Maeda-Chubachi T
J Drugs Dermatol; 2018 Oct; 17(10):1100-1105. PubMed ID: 30365591
[TBL] [Abstract][Full Text] [Related]
11. Treatment of external genital warts in men with imiquimod 2% in cream. A placebo-controlled, double-blind study.
Syed TA; Hadi SM; Qureshi ZA; Ali SM; Kwah MS
J Infect; 2000 Sep; 41(2):148-51. PubMed ID: 11023759
[TBL] [Abstract][Full Text] [Related]
12. Polyhexamethylene biguanide for treatment of external genital warts: a prospective, double-blind, randomized study.
Marelli G; Papaleo E; Origoni M; Caputo L; Ferrari A
Eur Rev Med Pharmacol Sci; 2005; 9(6):369-72. PubMed ID: 16479742
[TBL] [Abstract][Full Text] [Related]
13. Cantharidin is Superior to Trichloroacetic Acid for the Treatment of Non-mucosal Genital Warts: A Pilot Randomized Controlled Trial.
Recanati MA; Kramer KJ; Maggio JJ; Chao CR
Clin Exp Obstet Gynecol; 2018; 45(3):383-386. PubMed ID: 30078935
[TBL] [Abstract][Full Text] [Related]
14. Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial.
Goldstone SE; Giuliano AR; Palefsky JM; Lazcano-Ponce E; Penny ME; Cabello RE; Moreira ED; Baraldi E; Jessen H; Ferenczy A; Kurman R; Ronnett BM; Stoler MH; Bautista O; Das R; Group T; Luxembourg A; Zhou HJ; Saah A
Lancet Infect Dis; 2022 Mar; 22(3):413-425. PubMed ID: 34780705
[TBL] [Abstract][Full Text] [Related]
15. Topical 0.3% and 0.5% podophyllotoxin cream for self-treatment of condylomata acuminata in women. A placebo-controlled, double-blind study.
Syed TA; Lundin S; Ahmad SA
Dermatology; 1994; 189(2):142-5. PubMed ID: 8075441
[TBL] [Abstract][Full Text] [Related]
16. Topical imiquimod: a review of its use in genital warts.
Perry CM; Lamb HM
Drugs; 1999 Aug; 58(2):375-90. PubMed ID: 10473026
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of 0.5% podofilox gel in the treatment of anogenital warts.
Tyring S; Edwards L; Cherry LK; Ramsdell WM; Kotner S; Greenberg MD; Vance JC; Barnum G; Dromgoole SH; Killey FP; Toter T
Arch Dermatol; 1998 Jan; 134(1):33-8. PubMed ID: 9449907
[TBL] [Abstract][Full Text] [Related]
18. Sinecatechins, a defined green tea extract, in the treatment of external anogenital warts: a randomized controlled trial.
Tatti S; Swinehart JM; Thielert C; Tawfik H; Mescheder A; Beutner KR
Obstet Gynecol; 2008 Jun; 111(6):1371-9. PubMed ID: 18515521
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of nitric-zinc complex in the treatment of external genital warts and "difficult-to-treat" warts: a "proof of concept", prospective, multicentre, open study.
Cusini M; Micali G; Lacarrubba F; Puviani M; Barcella A; Milani M
G Ital Dermatol Venereol; 2015 Dec; 150(6):643-8. PubMed ID: 26513041
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the Efficacy, Safety, and Tolerability of 3 Dose Regimens of Topical Sodium Nitrite With Citric Acid in Patients With Anogenital Warts: A Randomized Clinical Trial.
Ormerod AD; van Voorst Vader PC; Majewski S; Vanscheidt W; Benjamin N; van der Meijden W
JAMA Dermatol; 2015 Aug; 151(8):854-61. PubMed ID: 25922903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
